Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Intravitreal injection of commercially available ketorolac tromethamine in eyes with diabetic macular edema refractory to laser photocoagulation.

Maldonado RM, Vianna RN, Cardoso GP, de Magalhães AV, Burnier MN Jr.

Curr Eye Res. 2011 Aug;36(8):768-73. doi: 10.3109/02713683.2011.585734.

PMID:
21780926
2.

[Intravitreal injection of ketorolac tromethamine in patients with diabetic macular edema refractory to retinal photocoagulation].

Reis Ado C, Vianna RN, Reis RS, Cardoso GP.

Arq Bras Oftalmol. 2010 Jul-Aug;73(4):338-42. Portuguese.

3.

Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema.

Batioğlu F, Ozmert E, Parmak N, Celik S.

Int Ophthalmol. 2007 Oct;27(5):299-306. Epub 2007 Apr 24.

PMID:
17453151
4.

Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.

Mirshahi A, Shenazandi H, Lashay A, Faghihi H, Alimahmoudi A, Dianat S.

Retina. 2010 Feb;30(2):254-9. doi: 10.1097/IAE.0b013e3181b4f125.

PMID:
20057344
5.

Intravitreal triamcinolone for refractory diabetic macular edema.

Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, Baumal C.

Ophthalmology. 2002 May;109(5):920-7.

PMID:
11986098
6.

Intravitreal triamcinolone improves vision in eyes with chronic diabetic macular oedema refractory to laser photocoagulation.

Negi AK, Vernon SA, Lim CS, Owen-Armstrong K.

Eye (Lond). 2005 Jul;19(7):747-51.

PMID:
15359268
7.

[Macular thickness analysis by optic coherence tomography in refractory diabetic macular edema treated with intravitreous triamcinolone].

Pinheiro A, Serracarbassa PD, Maia OO Jr, Takahashi WY.

Arq Bras Oftalmol. 2007 Sep-Oct;70(5):784-9. Portuguese.

8.

[Intravitreal triamcinolone combined with grid laser photocoagulation for patients with cystoid macular edema and advanced diabetic retinopathy: pilot study].

Arévalo JF, Fernández CF, Mendoza AJ, García RA, Arévalo FA.

Arch Soc Esp Oftalmol. 2013 Oct;88(10):373-9. doi: 10.1016/j.oftal.2013.01.020. Epub 2013 May 29. Spanish.

PMID:
24060300
9.

Intravitreal triamcinolone versus laser photocoagulation for persistent diabetic macular oedema.

Ockrim ZK, Sivaprasad S, Falk S, Roghani S, Bunce C, Gregor Z, Hykin P.

Br J Ophthalmol. 2008 Jun;92(6):795-9. doi: 10.1136/bjo.2007.131771. Epub 2008 Apr 17.

PMID:
18420749
10.

Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.

Cakir M, Dogan M, Bayraktar Z, Bayraktar S, Acar N, Altan T, Kapran Z, Yilmaz OF.

Retina. 2008 Mar;28(3):465-72. doi: 10.1097/IAE.0b013e318154b9d1.

PMID:
18327140
11.

[Treatment of diabetic macular edema with intravitreal triamcinolone acetonide injection: functional and anatomical outcomes].

Selim Kocabora M, Kucuksahin H, Gulkilik G, Taskapili M, Yilmazli C, Engin G.

J Fr Ophtalmol. 2007 Jan;30(1):32-8. French.

12.

Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes.

Lam DS, Chan CK, Mohamed S, Lai TY, Lee VY, Liu DT, Li KK, Li PS, Shanmugam MP.

Ophthalmology. 2007 Dec;114(12):2162-7. Epub 2007 Apr 25.

PMID:
17459479
13.

Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial.

Massin P, Audren F, Haouchine B, Erginay A, Bergmann JF, Benosman R, Caulin C, Gaudric A.

Ophthalmology. 2004 Feb;111(2):218-24; discussion 224-5.

PMID:
15019365
14.
15.

The effect of intravitreal triamcinolone on diabetic macular oedema.

Krepler K, Wagner J, Sacu S, Wedrich A.

Graefes Arch Clin Exp Ophthalmol. 2005 May;243(5):478-81. Epub 2004 Dec 7.

PMID:
15586288
16.

Triple therapy of vitrectomy, intravitreal triamcinolone, and macular laser photocoagulation for intractable diabetic macular edema.

Kang SW, Park SC, Cho HY, Kang JH.

Am J Ophthalmol. 2007 Dec;144(6):878-885. Epub 2007 Oct 15.

PMID:
17936715
17.

Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.

Gillies MC, Sutter FK, Simpson JM, Larsson J, Ali H, Zhu M.

Ophthalmology. 2006 Sep;113(9):1533-8. Epub 2006 Jul 7.

PMID:
16828501
18.

Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular edema.

Sivaprasad S, Ockrim Z, Massaoutis P, Ikeji F, Hykin PG, Gregor ZJ.

Retina. 2008 Nov-Dec;28(10):1435-42. doi: 10.1097/IAE.0b013e31817f2dae.

PMID:
18628722
19.

Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial.

Audren F, Erginay A, Haouchine B, Benosman R, Conrath J, Bergmann JF, Gaudric A, Massin P.

Acta Ophthalmol Scand. 2006 Oct;84(5):624-30.

Supplemental Content

Support Center